Brief: Neurizon Therapeutics Posts Loss For Half Year Attributable Of A$5.5 Million
25/02/2026 01:46
Feb 25 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX: LOSS FOR HALF YEAR ATTRIBUTABLE A$5.5 MILLION HY OTHER INCOME A$6 MILLION Further company coverage: NUZ.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon Therapeutics jumps on deal with US firm
Brief: Neurizon Therapeutics Executes Long-Term Supply Agreement With Elanco
Brief: Neurizon Therapeutics Receives Ethics Approval For Phase 1 Nuz-001 Oral Liquid Formulation Study
Brief: Neurizon Therapeutics Announces Placement Of Entitlement Offer Shortfall To Raise ~A$2.7 Million
Brief: Neurizon Therapeutics Says Michael Thurn Resigns As Managing Director And CEO